Top Markets
#1 CyberDEX CyberDEX +391.95%
#2 OVERTAKE OVERTAKE +58.99%
#3 Clearpool Clearpool +25.94%
#4 Playnance Playnance +23.93%
#5 deBridge deBridge +22.97%
#6 B3 (Base) B3 (Base) +20.83%
#7 Nillion Nillion +19.56%
#8 AUKI AUKI +19.09%
#9 Codatta Codatta +17.25%
#10 龙虾 (Lobster) 龙虾 (Lobster) +17.03%
Coin of the day
CyberDEX CyberDEX
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Nuformix plc Nuformix plc

Nuformix plc

NFX
Classifica tra le azioni #41014
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Prezzo delle azioni
$0.00185055
Capitalizzazione di mercato
$48.29K
Variazione (1 giorno)
-3.55%
Variazione (1 anno)
30.31%
Paese
GB
Scambia Nuformix plc (NFX)

Categoria

Healthcare
Rapporto P/S per Nuformix plc (NFX)
Rapporto P/S al September 2026 TTM: 0.00
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Nuformix plc, il rapporto P/S attuale (TTM) è 0.00. Alla fine del 2024, era pari a 0.00.
Storico del rapporto P/S per Nuformix plc da 2014 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
2026 (TTM) 0.00 0.00%
2025 0.00 0.00%
2024 0.00 0.00%
2023 0.00 -100.00%
2022 116.70 74.68%
2021 66.81 87.30%
2020 35.67 81.62%
2019 19.64 -95.96%
2018 485.61 0.00%
2017 0.00 -100.00%
2016 2.23 0.00%
2014 0.00 0.00%
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.44 -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
26.12 -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.76 -
AU
Argenx SE Argenx SE
Argenx SE
ARGX.US
12.01 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH